| 7 | MAP Kinase Kinase Kinase 5IBA
01/2008
-
01/2002 |
| 5 | Phosphotransferases (Kinase)IBA
07/2007
-
02/2003 |
| 4 | Reactive Oxygen Species (Oxygen Radicals)IBA
05/2005
-
01/2002 |
| 4 | Phenylephrine (Neo-Synephrine)FDA LinkGeneric
02/2005
-
01/2002 |
| 4 | NF-kappa B (NF-kB)IBA
02/2005
-
01/2002 |
| 3 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2004
-
01/2002 |
| 2 | Pharmaceutical PreparationsIBA
07/2019
-
01/2018 |
| 2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008
-
02/2002 |
| 2 | AntioxidantsIBA
05/2005
-
03/2002 |
| 2 | Messenger RNA (mRNA)IBA
05/2005
-
03/2002 |
| 2 | p38 Mitogen-Activated Protein KinasesIBA
05/2005
-
02/2003 |
| 2 | Angiotensin IIIBA
10/2004
-
01/2002 |
| 2 | Endothelin-1 (Endothelin 1)IBA
06/2004
-
01/2002 |
| 2 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoic acid (5Z)-7-((1R,2RIBA
04/2004
-
12/2003 |
| 2 | Latanoprost (Xalatan)FDA Link
04/2004
-
12/2003 |
| 2 | Melanins (Melanin)IBA
04/2004
-
12/2003 |
| 2 | tafluprostIBA
04/2004
-
12/2003 |
| 2 | NF-KappaB Inhibitor alphaIBA
06/2003
-
01/2002 |
| 1 | pro-brain natriuretic peptide (1-76)IBA
10/2020 |
| 1 | Brain Natriuretic Peptide (Natrecor)FDA Link
10/2020 |
| 1 | Dextran SulfateIBA
05/2015 |
| 1 | Dinoprostone (PGE2)FDA Link
05/2015 |
| 1 | KAG-308IBA
05/2015 |
| 1 | Sulfasalazine (Azulfidine)FDA LinkGeneric
05/2015 |
| 1 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2013 |
| 1 | Lymphotoxin-alpha (Lymphotoxin)IBA
04/2013 |
| 1 | 4-hydroxy-2-nonenal (4-hydroxynonenal)IBA
01/2009 |
| 1 | IronIBA
01/2009 |
| 1 | ferric ferrocyanide (Prussian blue)FDA Link
01/2009 |
| 1 | 8-Hydroxy-2'-DeoxyguanosineIBA
01/2009 |
| 1 | Oxygen (Dioxygen)IBA
08/2008 |
| 1 | Hemoglobins (Hemoglobin)IBA
08/2008 |
| 1 | CalpainIBA
07/2007 |
| 1 | DystrophinIBA
07/2007 |
| 1 | Proteins (Proteins, Gene)FDA Link
05/2007 |
| 1 | Protein Kinases (Protein Kinase)IBA
05/2005 |
| 1 | Atrial Natriuretic Factor (ANF)IBA
05/2005 |
| 1 | EdaravoneIBA
05/2005 |
| 1 | Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
02/2005 |
| 1 | KN 93IBA
02/2005 |
| 1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2004 |
| 1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2004 |
| 1 | Focal Adhesion Kinase 2IBA
06/2004 |
| 1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2004 |
| 1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2004 |
| 1 | PhXa 85IBA
04/2004 |
| 1 | prostaglandin F2alpha receptorIBA
04/2004 |
| 1 | AFP-157IBA
12/2003 |
| 1 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoate 1-ethyl (5Z)-7-((1R,2RIBA
12/2003 |
| 1 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoate 1-methyl (5Z)-7-((1R,2RIBA
12/2003 |
| 1 | Carboxylic AcidsIBA
12/2003 |
| 1 | EstersIBA
12/2003 |
| 1 | Carrier Proteins (Binding Protein)IBA
06/2003 |
| 1 | Guanine NucleotidesIBA
06/2003 |
| 1 | rac1 GTP-Binding ProteinIBA
06/2003 |
| 1 | C-Reactive ProteinIBA
04/2003 |
| 1 | Mitogen-Activated Protein Kinase 14IBA
02/2003 |
| 1 | CalciumIBA
01/2003 |
| 1 | Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2002 |
| 1 | Heme Oxygenase-1IBA
03/2002 |
| 1 | MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
01/2002 |
| 1 | Heparin (Liquaemin)FDA LinkGeneric
01/2002 |
| 1 | Metalloproteases (Metalloproteinases)IBA
01/2002 |
| 1 | Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
01/2002 |
| 1 | KB R7785IBA
01/2002 |
| 1 | ErbB Receptors (EGF Receptor)IBA
01/2002 |
| 1 | Epidermal Growth Factor (EGF)IBA
01/2002 |